<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00375180</url>
  </required_header>
  <id_info>
    <org_study_id>HN-4-0030 / 23028</org_study_id>
    <nct_id>NCT00375180</nct_id>
  </id_info>
  <brief_title>Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients</brief_title>
  <official_title>Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients Prior to, on Completion of and Six Weeks After Oncology Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AHS Cancer Control Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cross Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AHS Cancer Control Alberta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hope to learn more about how side-effects of RT or RTchemo affect food&#xD;
      intake and nutrition status.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Head and neck cancer patients often have difficulty meeting their nutritional needs while&#xD;
      undergoing radiation therapy (RT) and/or chemotherapy (RTchemo). Tumor locations and side&#xD;
      effects of RT or RTchemo, including dry mouth, mouth sores, difficulty chewing and&#xD;
      swallowing, changes in taste and smell, and loss of appetite, lead to poor food intake and&#xD;
      weight loss. The investigators hope to learn more about how side-effects of RT or RTchemo&#xD;
      affect food intake and nutrition status.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">100</enrollment>
  <condition>Head and Neck Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Diagnosed with head and neck cancer including the lip, oral cavity, salivary glands,&#xD;
        paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx, and thyroid&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Diagnosed with head and neck cancer including the lip, oral cavity, salivary glands,&#xD;
             paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx, and thyroid&#xD;
&#xD;
          -  All histological types of cancer&#xD;
&#xD;
          -  All tumour stages according to American Joint Committee for Cancer (AJCC) Staging&#xD;
&#xD;
          -  All forms of RT including standard or investigational and/or concurrent standard or&#xD;
             investigational chemotherapy for head and neck cancers&#xD;
&#xD;
          -  Alert and mentally competent&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vickie Baracos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AHS Cancer Control Alberta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cross Cancer Institute</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <study_first_submitted>September 11, 2006</study_first_submitted>
  <study_first_submitted_qc>September 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2006</study_first_posted>
  <last_update_submitted>February 24, 2016</last_update_submitted>
  <last_update_submitted_qc>February 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>food</keyword>
  <keyword>diet</keyword>
  <keyword>mucositis</keyword>
  <keyword>xerostomia</keyword>
  <keyword>dysphagia</keyword>
  <keyword>taste</keyword>
  <keyword>smell</keyword>
  <keyword>head and neck</keyword>
  <keyword>radiation</keyword>
  <keyword>chemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

